This guideline was developed collaboratively by the SNMMI with the American Society of Nuclear Cardiology (ASNC) and the Society of Cardiovascular CT (SCCT). Since 2002, there has been a rapid evolution of hybrid imaging technology incorporating high-quality multidetectorrow CT technology, along with the latest SPECT and PET detector systems. The increasing clinical use of these hybrid systems for cardiovascular radionuclide studies necessitates the establishment of guidelines to ensure reliable use and practice of this technology.
The joint EANM/ESC/ECNC guidelines provide recommendations on the use of hybrid imaging in cardiology. Hybrid cardiac imaging with SPECT or PET combined with CT depicts cardiac and vascular anatomical abnormalities and their physiologic consequences in a single setting and appears to offer superior information compared with either stand-alone or side-by-side interpretation of the data sets in patients with known or suspected coronary artery disease.
The American College of Cardiology (ACC) and the American Heart Association (AHA) Task Force on Practice Guidelines was formed to make recommendations regarding the appropriate use of testing and technology in the diagnosis and treatment of patients with known or suspected cardiovascular disease. Cardiac radionuclide imaging (nuclear cardiology) is one such important technology.
The purpose of this guideline is to assist nuclear medicine practitioners in recommending, performing, interpreting, and reporting the results of myocardial perfusion imaging studies.
Radionuclide imaging protocols of cardiac function represent a number of well-validated techniques providing an accurate assessment of right (RV) and left ventricular (LV) ejection fraction (EF), regional wall motion, thickening and LV volumes.
The joint EANM/ESC guidelines provide recommendations on the use of first-pass and equilibrium radionuclide ventriculography, gated myocardial perfusion scintigraphy, gated PET, and studies with non-imaging devices for the evaluation of cardiac ejection function. The included items herewith are subdivided into 11 sections: clinical indications, radiopharmaceuticals and dosimetry, study acquisition protocols, RV EF, LV EF, LV volumes, LV regional function, LV diastolic function, image display and analysis and reporting. Reference normal values of the RVEF, LVEF and LV volumes are also provided.
The American College of Cardiology (ACC) and the American Heart Association (AHA) have jointly engaged in the production of guidelines in the area of cardiovascular disease since 1980. These particular guidelines are intended for health professionals who are involved in the preoperative, operative, and postoperative care of patients undergoing noncardiac surgery.
The European procedural guidelines for radionuclide imaging of myocardial perfusion and viability are presented in 13 sections covering patient information, radiopharmaceuticals, injected activities and dosimetry, stress tests, imaging protocols and acquisition, quality control and reconstruction methods, gated studies and attenuation scatter compensation, data analysis, reports and image display, and positron emission tomography.
The purpose of this guideline is to assist nuclear medicine practitioners in recommending, performing, interpreting, and reporting the results of gated equilibrium radionuclide ventriculography.